ā­ļøā­ļøā­ļøā­ļøā­ļø "A total no brainer"

ā­ļøā­ļøā­ļøā­ļøā­ļø "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for hh1

Every month we try and update this database with for hh1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)NCT02658968
Relapsed, Diffu...
Refractory Diff...
Betalutin
18 Years - Nordic Nanovector
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)NCT02658968
Relapsed, Diffu...
Refractory Diff...
Betalutin
18 Years - Nordic Nanovector
Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)NCT02657447
Non-Hodgkin Lym...
Betalutin with ...
Betalutin with ...
18 Years - Nordic Nanovector
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)NCT02658968
Relapsed, Diffu...
Refractory Diff...
Betalutin
18 Years - Nordic Nanovector
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: